EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Anti-GAD65 antibody-associated cerebellar ataxia in a young adult with type 1 diabetes: a case report and literature review

Büşra Karaca iD, Emre Gezer, Aydan Dağdaş, Berrin Çetinarslan, Zeynep Cantürk, Alev Selek, Mehmet Sözen, Özlem Alkan, Saadet Acar, Fatma Öktem

Diabetology International · 2026-10 · 17 (4)

DOI: 10.1007/s13340-026-00920-7 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Diabetology International, online erschienen am 10.08.2026. Verfasst von Büşra Karaca und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Department of Endocrinology and Metabolism, Kocaeli University, Umuttepe Kampüsü, 41380 Kocaeli, Turkey. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia (anti-GAD-CA) is a rare autoimmune neurological disorder. Although frequently associated with latent autoimmune diabetes in adults (LADA), it can occasionally coexist with type 1 diabetes mellitus (T1DM). Case: We report a 27-year-old woman with a 14-year history of T1DM who presented with subacute onset of balance impairment, vertigo, and hypophonic speech. Neurological examination and laboratory investigations were consistent with cerebellar ataxia. The patient exhibited high titers of anti-glutamic acid decarboxylase (anti-GAD) in both serum (619 IU/mL) and cerebrospinal fluid. Brain MRI was unremarkable. After a 5-day intravenous immunoglobulin (IVIG) therapy, the patient showed notable improvement in tandem gait and speech fluency. Her glycemic control also improved significantly, with the glycated hemoglobin (HbA1c) dropping from 9.7 to 6.8% over two months. Follow-up testing showed a steady decline in serum anti-GAD levels to 229 IU/mL.

Conclusion

This case represents one of the youngest reported patients with anti-GAD-CA in the context of long-standing T1DM. The case emphasizes the importance of considering anti-GAD-CA in patients with unexplained cerebellar signs and autoimmune diabetes, even in younger individuals. Furthermore, the observed parallel improvements in neurological and glycemic parameters following immunotherapy may provide insight into the interplay between anti-GAD autoimmunity and metabolic control. Further studies are required to better understand the pathophysiological mechanisms and optimize management strategies.

Schlagwörter

Stichwörter der Autor:innen

Anti-glutamic acid decarboxylase antibodiesAutoimmune neurological disorderCerebellar ataxiaType 1 diabetes

Autor:innen und Institutionen

  • Faculty of Medicine, Department of Endocrinology and Metabolism, Kocaeli University, Umuttepe Kampüsü, 41380 Kocaeli, Turkey.
  • Department of Neurology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey.

ORCID-Profile: Büşra Karaca

Zitieren

APA

Karaca, B., Gezer, E., Dağdaş, A., Çetinarslan, B., Cantürk, Z., Selek, A., Sözen, M., Alkan, Ö., Acar, S., & Öktem, F. (2026). Anti-GAD65 antibody-associated cerebellar ataxia in a young adult with type 1 diabetes: a case report and literature review. Diabetology International, 17(4). https://doi.org/10.1007/s13340-026-00920-7

Vancouver

Karaca B, Gezer E, Dağdaş A, Çetinarslan B, Cantürk Z, Selek A, et al. Anti-GAD65 antibody-associated cerebellar ataxia in a young adult with type 1 diabetes: a case report and literature review. Diabetology International. 2026;17(4). doi:10.1007/s13340-026-00920-7

BibTeX
@article{Karaca2026,
  author = {Karaca, Büşra and Gezer, Emre and Dağdaş, Aydan and Çetinarslan, Berrin and Cantürk, Zeynep and Selek, Alev and Sözen, Mehmet and Alkan, Özlem and Acar, Saadet and Öktem, Fatma},
  title = {Anti-GAD65 antibody-associated cerebellar ataxia in a young adult with type 1 diabetes: a case report and literature review},
  journal = {Diabetology International},
  year = {2026},
  volume = {17},
  number = {4},
  doi = {10.1007/s13340-026-00920-7}
}
Kostenlos starten →